- Home
- OCUL vs DBD Comparison
OCUL vs DBD Comparison
Compare OCUL & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- DBD
- Stock Information
- Founded
- OCUL 2006
- DBD 1859
- Country
- OCUL United States
- DBD United States
- Employees
- OCUL N/A
- DBD N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- DBD EDP Services
- Sector
- OCUL Health Care
- DBD Technology
- Exchange
- OCUL Nasdaq
- DBD Nasdaq
- Market Cap
- OCUL 2.3B
- DBD 2.2B
- IPO Year
- OCUL 2014
- DBD N/A
- Fundamental
- Price
- OCUL $12.17
- DBD $59.04
- Analyst Decision
- OCUL Strong Buy
- DBD Strong Buy
- Analyst Count
- OCUL 7
- DBD 2
- Target Price
- OCUL $17.83
- DBD $75.00
- AVG Volume (30 Days)
- OCUL 2.2M
- DBD 191.2K
- Earning Date
- OCUL 11-13-2025
- DBD 11-06-2025
- Dividend Yield
- OCUL N/A
- DBD N/A
- EPS Growth
- OCUL N/A
- DBD N/A
- EPS
- OCUL N/A
- DBD N/A
- Revenue
- OCUL $56,664,000.00
- DBD $3,672,300,000.00
- Revenue This Year
- OCUL N/A
- DBD $3.09
- Revenue Next Year
- OCUL $18.87
- DBD $2.74
- P/E Ratio
- OCUL N/A
- DBD N/A
- Revenue Growth
- OCUL N/A
- DBD N/A
- 52 Week Low
- OCUL $5.79
- DBD $34.88
- 52 Week High
- OCUL $13.85
- DBD $63.46
- Technical
- Relative Strength Index (RSI)
- OCUL 46.53
- DBD 44.29
- Support Level
- OCUL $12.27
- DBD $59.07
- Resistance Level
- OCUL $13.07
- DBD $60.45
- Average True Range (ATR)
- OCUL 0.62
- DBD 1.21
- MACD
- OCUL -0.10
- DBD -0.32
- Stochastic Oscillator
- OCUL 7.92
- DBD 0.00
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.